Regulator restricts use of SSRIs in children
BMJ 2005; 330 doi: https://doi.org/10.1136/bmj.330.7498.984-a (Published 28 April 2005) Cite this as: BMJ 2005;330:984- Lynn Eaton
- London
The European Medicines Agency has ruled that selective serotonin reuptake inhibitors (SSRIs) and selective serotonin and norepinephrine reuptake inhibitors (SNRIs) should not be prescribed for children and adolescents under the age of 18, except for limited, approved uses. Some of the drugs have been approved for obsessive compulsive disorder, and one of them has been approved for attention deficit/hyperactivity disorder.
It is also recommending that strong warnings should be issued throughout the European Union about the potential risk of suicidal behaviour and aggression in these age groups.
The advice …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.